药物对比
Insulin Aspart Human vs Rosiglitazone
Insulin Aspart是一种用于控制糖尿病血糖的速效注射用胰岛素，而Rosiglitazone是一种改善胰岛素敏感性的口服药物。
此页面暂无可用的对比维度。
临床背景
Patients with diabetes are comparing Insulin Aspart and Rosiglitazone when deciding between injectable and oral antidiabetic therapies.
结论
The choice between Insulin Aspart and Rosiglitazone depends on the patient's specific diabetes type and needs rather than one being better overall.
全部药物对比